教員情報 - 山﨑　啓之

ヤマサキ　ケイシ Yamasaki Keishi
山﨑　啓之

所属薬学部薬学科

職種教授

著書・論文歴
1.	2026	論文	Mechanistic Insights into pH-Responsive Drug Release and Antitumor Effects of an Albumin-Pirarubicin Conjugate. Pharm Res (共著)
2.	2026	論文	Caspase-Independent Cell Death Induced by a Nitric Oxide Donor Derived from Valproic Acid in Human Pancreatic Cancer Cells. Biol Pharm Bull 49,452-456頁 (共著)
3.	2025	論文	Insights into the renal protective effects of 7-phenylheptanoic acid in chronic kidney disease mice: modulation of indoxyl sulfate production and gut microbiome homeostasis doi: 10.1016/j.dmd.2025.100149 (共著)
4.	2025	論文	Secreted protein acidic and rich in cysteine-guided biomimetic delivery of nano-antioxidants reverses muscle atrophy in a mouse model of sarcopenia. (共著)
5.	2025	論文	Insights into Dual Binding Modes of Nateglinide to Human Serum Albumin. ACS Med Chem Lett doi: 10.1021/acsmedchemlett.5c00277 (共著)
6.	2025	論文	Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages. Molecular cancer 24 (1),132 (共著)
7.	2025	著書	Crosslink 薬学テキスト薬物動態学 (共著)
8.	2026	論文	Preparation and evaluation of hydrophobin-pirarubicin glucosamine-containing nanoparticles as an anticancer formulation. Int J Biol Macromol.,150460 (共著)
9.	2025	論文	新学習指導要領を意識したアドミッション・ポリシーの改定薬学教育 9,e90002 (共著)
10.	2024	論文	Interaction of Cephalosporins with Human Serum Albumin: A Structural Study. J Med Chem 67,14175-14183頁 (共著)
11.	2024	論文	The preparation and evaluation of granulated chitosan-catechin tablets with excellent disintegration properties. Carbohydr Res. 547,109308 (共著)
12.	2024	論文	Qualitative and quantitative status of cytochrome P450s after the administration of a liposomal platelet substitute in rat liver. (共著)
13.	2024	論文	Ibuprofen‑derived nitric oxide donors with a high affinity to human serum albumin induce cell death in pancreatic cancer cells through a non‑caspase 3/7‑mediated pathway. Biomed Rep 21,159 (共著)
14.	2024	論文	Novel Diclofenac-NO Donor With High Affinity for Human Serum Albumin Induces Endoplasmic Reticulum Stress-mediated Cell Death in Human Pancreatic Cancer Cells. Anticancer Res 44,3793-3798頁 (共著)
15.	2024	論文	7-Phenylheptanoic acid-Hydroxypropyl β-Cyclodextrin Complex Slows the Progression of Renal Failure in Adenine-Induced Chronic Kidney Disease Mice. Toxins 16,316 (共著)
16.	2024	論文	Possible Involvement of Protein Binding Inhibition in Changes in Dexmedetomidine Concentration in Extracorporeal Circuits during Midazolam Use. Biological & pharmaceutical bulletin 47 (2),389-393 (共著)
17.	2024	論文	Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate. Pharmaceutics 16,82 (共著)
18.	2024	論文	Preparation and in vitro characterization of fatty-acid modified pirarubicin nanosuspensions stabilized by albumin. Chem Pharm Bull 72,21-27頁 (共著)
19.	2023	論文	Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency. Int J Mol Sci 24,15091 (共著)
20.	2023	論文	Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticles for the Treatment of Hepatitis. ACS Nano doi: 10.1021/acsnano.3c02877 (共著)
21.	2023	論文	メトロニダゾール誘発性脳症患者の1例－血清中メトロニダゾールおよびヒドロキシメトロニダゾール濃度－中毒研究 36,38-43頁 (共著)
22.	2023	論文	Structural basis of the change in the interaction between mycophenolic acid and subdomain IIA of human serum albumin during renal failure. J Med Chem 66,951-961頁 (共著)
23.	2023	論文	Study of the Inclusion Complexes Formed Between 4-Phenylbutyrate and α-, β-, and γ-Cyclodextrin in Solution and Evaluation on Their Taste-Masking Properties. J Pharm Pharmacol 75,236-244頁 (共著)
24.	2022	論文	The Chlorine Atoms of Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in the Subdomain IIIA of Human Serum Albumin. ACS Omega doi.org/10.1021/acsomega.2c02929 (共著)
25.	2022	論文	An in vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. J Pharm Pharmacol 74,88-93頁 (共著)
26.	2022	論文	Novel nitric oxide donor, nitrated phenylbutyrate, induces cell death of human pancreatic cancer cells and suppress tumor growth of cancer xenografts. Oncology Reports 48,178 (共著)
27.	2022/03	論文	The Nitrated Form of Nateglinide Induces Apoptosis in Human Pancreatic Cancer Cells Through a Caspase-dependent Mechanism. Anticancer research 42 (3),1333-1338 (共著)
28.	2022	論文	Effect of Fatty Acids and Uremic Toxins on the binding of Nateglinide, an Insulin Secretagogue, to Site II on Human Serum Albumin Biol. Pharm. Bull. 45,803-805頁 (共著)
29.	2022	論文	Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural–Chemical Investigation ACS OMEGA 7 (5),4413-4419頁 (共著)
30.	2022	論文	In vitro and in vivo assessment of Atemoya fruit (Annona atemoya) for food-drug interaction. Eur J Drug Metab Pharmacokinet 47,177-185頁 (共著)
31.	2022	論文	Trimethoxy trityl groups as a potent substituent for anti-cancer cytidine analog prodrugs. J Pharm Sci doi: 10.1016/j.xphs.2022.04.020 (共著)
32.	2021	論文	The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients toxins 13,811 (共著)
33.	2021	論文	Possible role of electrolytes on the formation of precipitates during the infusion of nafamostat mesilate in hemodialysis Biol Pharm Bull 44 (2),259-265頁 (共著)
34.	2021	論文	Interaction of benzbromarone with subdomains IIIA and IB/IIA on human serum albumin as the primary and secondary binding regions. Mol Pharm doi: 10.1021/acs.molpharmaceut.0c01004 (共著)
35.	2021	論文	Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin. Biol Pharm Bull 44 (3),437-441頁 (共著)
36.	2021	論文	Evaluation of Storage Stability of Acetic Acid Ointments as Hospital Preparations Jpn J Pharm Health Care 47 (3),171-177頁 (共著)
37.	2021	論文	Possible roles of intestinal P-glycoprotein and cytochrome P450 3A on the limited oral absorption of irinotecan. J Pharm Pharmacol. (共著)
38.	2021	論文	Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease. J Infect Chemother 27,702-706頁 (共著)
39.	2021	論文	Antipruritic and anti-herpes virus activities of bisabolol oxide A, the main constituent in the essential oil of German chamomile (Matricaria recutita L.) Cur Top Phytochem 17,63-68頁 (共著)
40.	2021/09	その他	今、医薬品の“品質”について思うこと病薬にゅーす 54,4-5頁 (単著)
41.	2020	論文	Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity. J Pharm Pharmacol doi: 10.1111/jphp.13212 (共著)
42.	2020	論文	Characterization of the interaction of daptomycin with site II on human serum albumin. Journal of pharmaceutical sciences https://doi.org/10.1016/j.xphs.2020.06.011 (共著)
43.	2020	論文	Effects of Oxidation of Human Serum Albumin on the Binding of Aripiprazole. Biol Pharm Bull 43,1023-1026頁 (共著)
44.	2020	論文	Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique Chem Pharm Bull (Tokyo) . 68 (8),766-772頁 (共著)
45.	2020	論文	Hepatic cytochrome P450 profiles in hemorrhagic shock model rats after transfusion with stored red blood cells. J Pharm Sci doi: 10.1016/j.xphs.2020.08.015. (共著)
46.	2020	論文	Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats. Biological & pharmaceutical bulletin 43 (9),1426-1429 (共著)
47.	2020	論文	Evaluation of cytochrome P450-based drug metabolism in hemorrhagic shock rats that were transfused with native and an artificial red blood cell preparation, Hemoglobin-vesicles. 35,417-424頁 (共著)
48.	2020	論文	Assessing cytochrome P450-based drug-drug interactions with Hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats. doi.org/10.1016/j.dmpk.2020.06.005 (共著)
49.	2020	論文	A Safety Evaluation Study in Mice Revealed that Albumin Dimer is Safe for Medical and Pharmaceutical Applications BPB Reports 3 (2),87-91頁 (共著)
50.	2020	論文	Serum Albumin, Lipid and Drug Binding 94,383-397頁 (共著)
51.	2020/06	その他	薬剤師国家試験問題から実務実習の重要性を再認識する (単著)
52.	2020	論文	In Vivo Evaluation of Drug Dialyzability in a Rat Model of Hemodialysis PLoS One 15 (6),e0233925 (共著)
53.	2019	論文	Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique. Cancer Chemother Pharmacol. 83,1113-1120頁 (共著)
54.	2019	論文	Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying. European journal of pharmaceutical science 139,105064 (共著)
55.	2019	論文	Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin. J Pharm Sci. 108,1890-1895頁 (共著)
56.	2019	論文	Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models. Journal of Drug Delivery Science and Technology (共著)
57.	2019/07	論文	α₁-Acid Glycoprotein Has the Potential to Serve as a Biomimetic Drug Delivery Carrier for Anti-Cancer Agents. Journal of pharmaceutical sciences (共著)
58.	2019	論文	Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer ACS Omega 4,8693-8700頁 (共著)
59.	2019/09	論文	Interaction of Aripiprazole with Human α1-Acid Glycoprotein. Journal of pharmaceutical sciences (共著)
60.	2018	論文	Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives. Chemical & pharmaceutical bulletin 66 (4),382-390 (共著)
61.	2018	論文	Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure. ACS omega 3 (10),13790-13797 (共著)
62.	2018/11	論文	Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity. Drug delivery 25 (1),1266-1274 (共著)
63.	2018/07	論文	Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites. Biochemistry and biophysics reports 14,155-160 (共著)
64.	2018/06	論文	Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats. The Journal of pharmacy and pharmacology 70 (6),723-731 (共著)
65.	2018/04	著書	最新薬剤学　第11版 (共著)
66.	2018/03	論文	Effect of endogenous substances on the binding of sodium 4-phenylbutyrate to human serum albumin. Acta Chim Pharm Indica 8,124-129頁 (共著)
67.	2018/03	論文	Effect of endogenous substances on the binding of sodium 4-phenylbutyrate to human serum albumin. Acta Chim Pharm Indica 8,124-129頁 (共著)
68.	2018/03	論文	Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate. Biochemistry and biophysics reports 13,78-82 (共著)
69.	2018/01	論文	Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core. Journal of pharmaceutical sciences 107 (1),436-445 (共著)
70.	2018/04	その他	薬剤師国家試験問題を解いてみましょう熊薬会報 (単著)
71.	2018	論文	Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats. PloS one 13 (6),e0198636 (共著)
72.	2018	論文	In vivo drug delivery eﬃciency of albumin-encapsulated liposomes as hydrophobic drug carriers Journal of Drug Delivery Science and Technology 47,62-66頁 (共著)
73.	2018	論文	Glutamine deprivation enhances acetyl-CoA carboxylase inhibitor-induced death of human pancreatic cancer cells. Anticancer Res 38,6683-6689頁 (共著)
74.	2017/12	論文	Interaction of Protizinic Acid with Human Serum Albumin: Site-to-Site Displacement of Protizinic Acid by Ibuprofen Acta Chim Pharm Indica 7 (3),115-123頁 (共著)
75.	2017/09	論文	The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders. Journal of pharmaceutical sciences 106 (9),2392-2400 (共著)
76.	2017/09	論文	Species Differences in the Binding of Sodium 4-Phenylbutyrate to Serum Albumin. Journal of pharmaceutical sciences 106 (9),2860-2867 (共著)
77.	2017/08	論文	Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions. Biochimica et biophysica acta. Proteins and proteomics 1865 (8),979-984 (共著)
78.	2017/03	論文	Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers. Journal of functional biomaterials 8 (1) (共著)
79.	2017	論文	The Binding of Silibinin, the Main Constituent of Silymarin, to Site I on Human Serum Albumin. Biological & pharmaceutical bulletin 40 (3),310-317 (共著)
80.	2017	論文	Recombinant Human Serum Albumin Containing 3 Copies of Domain I, Has Significant in Vitro Antioxidative Capacity Compared to the Wild-Type. Biological & pharmaceutical bulletin 40 (10),1813-1817 (共著)
81.	2017	論文	Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. PloS one 12 (6),e0180404 (共著)
82.	2017	論文	Albumin-encapsulated liposomes: A novel drug delivery carrier with hydrophobic drugs encapsulated in the inner aqueous core. J Pharm Sci S0022-3549(17)30567-1. doi: 10 (共著)
83.	2016/10	論文	Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury. PloS one 11 (10),e0165557 (共著)
84.	2016/10	論文	Carbon monoxide-bound hemoglobin vesicles ameliorate multiorgan injuries induced by severe acute pancreatitis in mice by their anti-inflammatory and antioxidant properties. International journal of nanomedicine 11,5611-5620 (共著)
85.	2016/07	論文	N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan. Biochemistry and biophysics reports 6,266-274 (共著)
86.	2016/07	論文	Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis. Journal of controlled release : official journal of the Controlled Release Society 234,49-58 (共著)
87.	2016/06	論文	Tyrosine411 and Arginine410 of Human Serum Albumin Play an Important Role in the Binding of Sodium 4-Phenylbutyrate to Site II. Journal of pharmaceutical sciences 105 (6),1987-1994 (共著)
88.	2016/03	論文	Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations. Journal of pharmaceutical sciences 105 (3),1043-9 (共著)
89.	2016	論文	Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury. PloS one 11 (10),e0165557 (共著)
90.	2016	論文	Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study. Biological & pharmaceutical bulletin 39 (6),1000-6 (共著)
91.	2016/05	その他	「多職種連携」に感じること熊薬会報 (単著)
92.	2016	著書	Albumin in Medicine - Pathological and Clinical Applications (共著)
93.	2015/10	論文	Establishment of a model of acetaminophen-induced hepatotoxicity in different weekly-aged ICR mice. Laboratory animals 49 (4),294-301 (共著)
94.	2015/08	論文	Potential Use of Biological Proteins for Liver Failure Therapy. Pharmaceutics 7 (3),255-74 (共著)
95.	2015/02	論文	Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs. The Journal of pharmacy and pharmacology 67 (2),255-63 (共著)
96.	2015	論文	ラット消化管における塩酸イリノテカン内封高分子マイクロカプセルの吸収特性就実大学薬学雑誌 2,46-51頁 (共著)
97.	2015	論文	Interactions of Linezolid with Two Major Serum Proteins, Human Serum Albumin and Alpha-1 Acid Glycoprotein. J Pharmacol Clin Toxicol 3,1045 (共著)
98.	2015	論文	Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection. Biological & pharmaceutical bulletin 38 (10),1606-16 (共著)
99.	2014/09	論文	N-acetyl-l-methionine is a superior protectant of human serum albumin against photo-oxidation and reactive oxygen species compared to N-acetyl-L-tryptophan. Biochimica et biophysica acta 1840 (9),2806-12 (共著)
100.	2014	論文	Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin. PloS one 9 (2),e87919 (共著)
101.	2014	論文	An evaluation of novel biological activity in a crude extract from Hemerocallis fulva L. var. sempervirens M. Hotta. Natural product research 28 (23),2211-3 (共著)
102.	2013/12	論文	Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Life sciences 93 (25-26),1017-22 (共著)
103.	2013/12	論文	Albumin-drug interaction and its clinical implication. Biochimica et biophysica acta 1830 (12),5435-43 (共著)
104.	2013/04	論文	Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method. Nuclear medicine and biology 40 (3),366-70 (共著)
105.	2013	著書	Human Serum Albumin (共著)
106.	2011/11	論文	Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former. International journal of pharmaceutics 420 (1),34-42 (共著)
107.	2011/04	論文	Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding. IUBMB life 63 (4),277-85 (共著)
108.	2011	論文	エダラボン注射剤における先発医薬品および後発医薬品のラジカル消去活性比較新薬と臨牀 60,57-63頁 (共著)
109.	2011	著書	NEWパワーブック生物薬剤学、「第8章」
110.	2010/10	論文	Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach. Journal of pharmaceutical sciences 99 (10),4285-94 (共著)
111.	2010/09	論文	Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. International journal of pharmaceutics 397 (1-2),1-8 (共著)
112.	2010/07	論文	Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans. Die Pharmazie 65 (7),461-6 (共著)
113.	2010	論文	メンタルヘルスケアに配慮した教育を目的とした交流分析とストレス度評価日本未病システム学会雑誌 16,238-242頁 (共著)
114.	2010	著書	コンパス生物薬剤学、「第7章」
115.	2009/08	論文	Competitive displacement of serum protein binding of radiopharmaceuticals with amino acid infusion investigated with N-isopropyl-p-123I-iodoamphetamine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 50 (8),1378-83 (共著)
116.	2009	著書	今日のOTC薬、「高齢者」 (共著)
117.	2009	論文	CKDとサプリメント・OTC薬 Pharma Medica 27,41-45頁 (共著)
118.	2008/02	論文	Inhibitory effects of fruit juices on cytochrome P450 2C9 activity in vitro. Bioscience, biotechnology, and biochemistry 72 (2),406-11 (共著)
119.	2008/01	論文	Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin. Drug metabolism and disposition: the biological fate of chemicals 36 (1),81-6 (共著)
120.	2008	論文	薬剤耐性淋菌の年次推移日本薬剤師会雑誌 60,1129-1132頁 (共著)
121.	2008	論文	塩酸タムスロシン服用患者の意識調査に基づく剤形についての問題点薬学雑誌 128,291-297頁 (共著)
122.	2007/02	論文	The role of N-acetyl-methioninate as a new stabilizer for albumin products. Int J Pharm 329 (1-2),19-24 (共著)
123.	2007/02	論文	Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug metabolism and disposition: the biological fate of chemicals 35 (2),302-5 (共著)
124.	2007/02	論文	Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea. Cancer chemotherapy and pharmacology 59 (3),321-8 (共著)
125.	2007	論文	喀痰学と薬物活性 THE LUNG perspectives 15,47-52頁 (共著)
126.	2007	論文	薬袋のユーバーサルデザイン医療薬学 33,87-92頁 (共著)
127.	2007	著書	知っておきたい臨床検査値、「第Ⅱ部」 (共著)
128.	2007	論文	増え続ける「うつ」への対応　“抗うつ薬のCYPを介した薬物相互作用” 薬局 58,63-68頁 (共著)
129.	2007	論文	The role of N-acetyl-methioninate as a new stabilizer for albumin products. Int J Pharm 329,19-24 (共著)
130.	2006/11	論文	速崩壊性錠剤の口腔内崩壊時間と In Vitro 崩壊試験法の評価医療薬学 = Japanese journal of pharmaceutical health care and sciences 32 (11),1124-1132頁 (共著)
131.	2006/09	論文	塩酸アロチノロール製剤の品質評価 : 先発医薬品と後発医薬品の比較医療薬学 = Japanese journal of pharmaceutical health care and sciences 32 (9),898-905頁 (共著)
132.	2006/05	論文	各種茶飲料が薬物代謝酵素に及ぼす影響 : ヒトCYP 3A活性阻害作用の検討医療薬学 = Japanese journal of pharmaceutical health care and sciences 32 (5),392-399頁 (共著)
133.	2006/04	論文	Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochimica et biophysica acta 1764 (4),743-9 (共著)
134.	2006	論文	酢酸リュープロレリン製剤投与で誘起された前立腺がん患者の手根管症候群 42,1447-1450頁 (共著)
135.	2006/03	論文	Transient inhibition of cyp3a in rats by star fruit juice. Drug metabolism and disposition: the biological fate of chemicals 34 (3),343-5 (共著)
136.	2006	論文	ジェネリックを考える―適正使用のカギは薬剤師―　“ 品質評価の実際　－主な成分の研究－　塩酸アロチノロール” 調剤と情報 (2006年9月臨時増刊号),1347-1352 (共著)
137.	2005/12	論文	Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug metabolism and disposition: the biological fate of chemicals 33 (12),1911-9 (共著)
138.	2005/07	論文	血清分離剤入り滅菌真空採血管中での薬物血中濃度の変化医療薬学 = Japanese journal of pharmaceutical health care and sciences 31 (7),537-543頁 (共著)
139.	2005/05	論文	Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug metabolism and disposition: the biological fate of chemicals 33 (5),644-8 (共著)
140.	2005/04	論文	Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome. Drug metabolism and disposition: the biological fate of chemicals 33 (4),596-602 (共著)
141.	2005/03	論文	Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro. Biological & pharmaceutical bulletin 28 (3),549-52 (共著)
142.	2005	論文	天然高分子サプリメントに対する薬物の結合性評価医療薬学 31,744-748頁 (共著)
143.	2005	論文	血清中タクロリムス濃度の変動因子に関する検討－血清蛋白結合の観点から－九州保健福祉大学研究紀要 6,299-302頁 (共著)
144.	2005	論文	器質性感情障害に対するバルプロ酸ナトリウムの使用経験．九州神経精神医学 51,122-125頁 (共著)
145.	2005	論文	医薬品情報のユニバーサルデザイン(2)聴覚障害者の服薬指導支援用手話学習システムの開発医療薬学 31,435-444頁 (共著)
146.	2004/12	論文	Characterization of site I of human serum albumin using spectroscopic analyses: locational relations between regions Ib and Ic of site I. Journal of pharmaceutical sciences 93 (12),3004-12 (共著)
147.	2004/06	論文	Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug metabolism and disposition: the biological fate of chemicals 32 (6),581-3 (共著)
148.	2004	論文	医薬品情報のユニバーサルデザイン（１）－ビジュアル効果を活用した医薬品情報提供の有用性評価－医療薬学 30,608-613頁 (共著)
149.	2004	論文	ムコダインドライシロップの嗜好品との溶解・懸濁時における風味およびL-カルボシステインの安定性に対する影響医学と薬学 52,359-367頁 (共著)
150.	2004	論文	バルプロ酸ナトリウム投与が著効した身体表現性疼痛性障害を伴った気分変調症の1例精神科 5,245-248頁 (共著)
151.	2003/09	論文	Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans. Biological & pharmaceutical bulletin 26 (9),1371-3 (共著)
152.	2003	論文	市販の速崩壊錠の自動錠剤分包機への適応性日本病院薬剤師会雑誌 39,719-722頁 (共著)
153.	2003	論文	Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats. Pharm Res. 20,910-917頁 (共著)
154.	2001/12	論文	In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharmaceutical research 18 (12),1775-81 (共著)
155.	2001/05	論文	Effect of oxidative stress on the structure and function of human serum albumin. Pharmaceutical research 18 (5),632-9 (共著)
156.	2001/04	論文	Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharmaceutical research 18 (4),520-4 (共著)
157.	2000/05	論文	Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS PharmSciTech 1 (2),E12 (共著)
158.	1999/07	論文	Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochimica et biophysica acta 1432 (2),313-23 (共著)
159.	1996/07	論文	Mode of interaction of loop diuretics with human serum albumin and characterization of binding site. Pharmaceutical research 13 (7),1015-9 (共著)
160.	1996/07	論文	Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochimica et biophysica acta 1295 (2),147-57 (共著)
161.	1994/12	論文	Characterization of region Ic in site I on human serum albumin. Microenvironmental analysis using fluorescence spectroscopy. Biological & pharmaceutical bulletin 17 (12),1656-62 (共著)
162.	1994/10	論文	Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods. Pharmaceutical research 11 (10),1452-7 (共著)
163.	1993/11	論文	Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods. Biochemical pharmacology 46 (10),1721-31 (共著)
164.	1993/11	論文	Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin. Biological & pharmaceutical bulletin 16 (11),1169-74 (共著)
165.	1993/03	論文	Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group. Biochemical pharmacology 45 (5),1017-26 (共著)